Overview:

Summary

GlobalData's clinical trial report, “Retinitis Pigmentosa Global Clinical Trials Review, Q1, 2011"" provides data on the Retinitis Pigmentosa clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Retinitis Pigmentosa. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Retinitis Pigmentosa. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Retinitis Pigmentosa 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by Phase 17
In Progress Trials by Phase 18
Clinical Trials by Trial Status 19
Unaccomplished Trials of Retinitis Pigmentosa 20
Subjects Recruited Over a Period of Time 21
Prominent Sponsors 22
Top Companies Participating in Retinitis Pigmentosa Therapeutics Clinical Trials 24
Prominent Drug Comparison 26
Clinical Trial Profiles 27
Clinical Trial Overview of Top Companies 27
Neurotech Pharmaceuticals, Inc. 27
Clinical Trial Overview of Neurotech Pharmaceuticals, Inc. 27
R-Tech Ueno, Ltd. 28
Clinical Trial Overview of R-Tech Ueno, Ltd. 28
Okuvision GmbH 29
Clinical Trial Overview of Okuvision GmbH 29
Centocor Ortho Biotech, Inc. 30
Clinical Trial Overview of Centocor Ortho Biotech, Inc. 30
Pfizer Inc. 31
Clinical Trial Overview of Pfizer Inc. 31
Isis Pharmaceuticals, Inc. 32
Clinical Trial Overview of Isis Pharmaceuticals, Inc. 32
Allergan, Inc. 33
Clinical Trial Overview of Allergan, Inc. 33
Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
National Neurovision Research Institute 34
Clinical Trial Overview of National Neurovision Research Institute 34
Third Military Medical University 35
Clinical Trial Overview of Third Military Medical University 35
University of Sao Paulo 36
Clinical Trial Overview of University of Sao Paulo 36
Sheba Medical Center 37
Clinical Trial Overview of Sheba Medical Center 37
Johns Hopkins University 38
Clinical Trial Overview of Johns Hopkins University 38
University of California, San Francisco 39
Clinical Trial Overview of University of California, San Francisco 39
The University of Sydney 40
Clinical Trial Overview of The University of Sydney 40
Chiba University Hospital 41
Clinical Trial Overview of Chiba University Hospital 41
Nagoya City University Hospital 42
Clinical Trial Overview of Nagoya City University Hospital 42
Institute of Biomedical Research and Innovation Hospital 43
Clinical Trial Overview of Institute of Biomedical Research and Innovation Hospital 43
Montpellier University Hospital 44
Clinical Trial Overview of Montpellier University Hospital 44
Azienda Policlinico Umberto I 45
Clinical Trial Overview of Azienda Policlinico Umberto I 45
Tokyo Women's Medical University 46
Clinical Trial Overview of Tokyo Women's Medical University 46
Tehran University of Medical Sciences 47
Clinical Trial Overview of Tehran University of Medical Sciences 47
Semmelweis University 48
Clinical Trial Overview of Semmelweis University 48
Chiba University 49
Clinical Trial Overview of Chiba University 49
Osaka University 50
Clinical Trial Overview of Osaka University 50
Indian Council of Medical Research 51
Clinical Trial Overview of Indian Council of Medical Research 51
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 54"

List of Tables
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Zone, 2011* 7
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 9
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Retinitis Pigmentosa Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2011* 11
Retinitis Pigmentosa Therapeutics Clinical Trials, Europe, Top Five Countries, 2011* 12
Retinitis Pigmentosa Therapeutics Clinical Trials, North America, Top Countries, 2011* 13
Retinitis Pigmentosa Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2011* 14
Retinitis Pigmentosa Therapeutics Clinical Trials, Central and South America, Top Countries, 2011* 15
Retinitis Pigmentosa Therapeutics Clinical Trials, BRIC Countries, 2011* 16
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Phase, 2011* 17
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials In Progress by Phase 2011* 18
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Retinitis Pigmentosa Therapeutics Market, Global, Terminated Clinical Trials, 2011* 20
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 23
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 25
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 26
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Neurotech Pharmaceuticals, Inc., 2011* 27
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by R-Tech Ueno, Ltd., 2011* 28
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Okuvision GmbH, 2011* 29
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Centocor Ortho Biotech, Inc., 2011* 30
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2011* 31
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Isis Pharmaceuticals, Inc., 2011* 32
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2011* 33
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by National Neurovision Research Institute, 2011* 34
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Third Military Medical University, 2011* 35
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2011* 36
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2011* 37
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2011* 38
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2011* 39
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Sydney, 2011* 40
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University Hospital, 2011* 41
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Nagoya City University Hospital, 2011* 42
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Institute of Biomedical Research and Innovation Hospital, 2011* 43
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Montpellier University Hospital, 2011* 44
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Policlinico Umberto I, 2011* 45
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Women's Medical University, 2011* 46
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2011* 47
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Semmelweis University, 2011* 48
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2011* 49
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Osaka University, 2011* 50
Retinitis Pigmentosa Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2011* 51"

List of Figures
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Zone (%), 2011* 7
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Top Countries, 2011* 8
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2011* 10
Retinitis Pigmentosa Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2011* 11
Retinitis Pigmentosa Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2011* 12
Retinitis Pigmentosa Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2011* 14
Retinitis Pigmentosa Therapeutics Clinical Trials, BRIC Countries (%), 2011* 16
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Phase (%), 2011* 17
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2011* 18
Retinitis Pigmentosa Therapeutics Market, Global, Clinical Trials by Trial Status, 2011* 19
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 21
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Key Sponsors, 2011* 22
Retinitis Pigmentosa  Therapeutics Clinical Trials, Global, Top Companies by Phase, 2011* 24
Retinitis Pigmentosa Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2011* 26
GlobalData Methodology 53